AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Pre Hospital Triage of Patients at Intermediate and High Risk for ACS

RecruitingNAAges 18 Years - anyAllCyril Camaro
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

RESEARCH QUESTION: Is a treatment strategy that includes direct referral to a PCI center for intermediate to high-risk patients with non-ST elevation acute coronary syndrome (NSTE-ACS), both cost-effective and non-inferior for major adverse cardiac events (MACE)? HYPOTHESIS: Prehospital triage with the modified \[History-ECG-Age-Risk factors\] (HEAR) score and a high sensitivity (hs) point-of-care troponin (POCT) leads to a faster diagnosis of ACS, faster time to coronary angiography (CAG) and/or treatment with PCI, shorter length of stay, quicker availability of ambulances and more satisfaction and quality of life of patients. STUDY DESIGN: Randomized clinical trial. STUDY POPULATION: Patients โ‰ฅ18 years with an intermediate to high risk for NSTE -ACS (defined as a modified HEAR score โ‰ฅ 4) INTERVENTION: applying modified HEAR score and hs POCT to identify patients for direct rule out (ve

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age โ‰ฅ 18 years * All out-of-hospital patients with chest pain or symptoms suggestive of ACS with an indication for transfer to the (cardiac) emergency department to evaluate and rule out ACS * Modified HEAR(T) score โ‰ฅ 4 * The patient has been informed of the nature of the study, agrees to its provisions and has provided written informed consent. Exclusion Criteria: * Electrocardiographic ST-segment elevation (STEMI) * Patients with confirmed myocardial infarction, PCI or CABG \<14 days prior to inclu-sion * Patients presenting an obvious non-cardiac cause for the chest complaints who need evaluation at an emergency department, e.g. trauma, pneumothorax, sepsis, etc. * Patients in comatose state, defined as an EMV \<8 * Patients with known cognitive impairment * Pregnancy * Patients presenting with cardiogenic shock, defined as: systolic blood pressure \<90mmHg and heart rate \>100 and peripheral oxygen saturation \<90% (without oxygen administration) * Patients presenting with syncope * Patients presenting with signs of heart failure * Patients presenting with second or third degree atrioventricular block * Patients without known supraventricular tachycardia i.e. unknown atrial fibrillation (known atrial fibrillation with adequate rate control can be included) * Patients with known end-stage renal disease (dialysis and/or GFR \< 30 ml/min) * Patients without a pre-hospital 12-lead ECG performed or available * Patients suspicious of aortic dissection or pulmonary embolism * Communication issues with patient/language barrier * Any significant medical or mental condition, which in the Investigator's opinion may interfere with the patient's optimal participation in the study
๐Ÿ’Š

What it tests

  • Integrating the HEAR score and hs POC troponin into pre hospital triage decision-making:
๐Ÿ“

Where

3 sites
RAV Brabant midden-west-noord: post Haps
Haps, Netherlands
Radboudumc Nijmegen, The Netherlands
Nijmegen, Netherlands
Veiligheidsregio Gelderland-Zuid
Nijmegen, Netherlands
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy